1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Polycystic Kidney Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Polycystic Kidney Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Polycystic Kidney Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Polycystic Kidney Disease 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Polycystic Kidney Disease Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Otsuka Holdings Co., Ltd. 32
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 32
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Kadmon Corporation, LLC 37
Clinical Trial Overview of Kadmon Corporation, LLC 37
Merck and Co., Inc. 38
Clinical Trial Overview of Merck and Co., Inc. 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
Diablo Clinical Research, Inc. 40
Clinical Trial Overview of Diablo Clinical Research, Inc. 40
C. H. Boehringer Sohn AG and Co. KG 41
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 41
Boehringer Ingelheim Pharmaceuticals, Inc. 42
Clinical Trial Overview of Boehringer Ingelheim Pharmaceuticals, Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
Kyorin University 43
Clinical Trial Overview of Kyorin University 43
Federico II University 44
Clinical Trial Overview of Federico II University 44
Mario Negri Institute for Pharmacological Research 45
Clinical Trial Overview of Mario Negri Institute for Pharmacological Research 45
Mayo Clinic 46
Clinical Trial Overview of Mayo Clinic 46
Shanghai Changzheng Hospital 47
Clinical Trial Overview of Shanghai Changzheng Hospital 47
The National Institute of Diabetes and Digestive and Kidney Diseases 48
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 48
Toranomon Hospital 49
Clinical Trial Overview of Toranomon Hospital 49
Addenbrooke's Hospital 50
Clinical Trial Overview of Addenbrooke's Hospital 50
Assistance Publique - Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 51
Azienda Ospedaliera Ospedale Policlinico Consorziale 52
Clinical Trial Overview of Azienda Ospedaliera Ospedale Policlinico Consorziale 52
Five Key Clinical Profiles 53
Appendix 90
Abbreviations 90
Definitions 90
Research Methodology 91
Secondary Research 91
About GlobalData 92
Contact Us 92
Disclaimer 92
Source 93

List of Tables
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Polycystic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Polycystic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Polycystic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Polycystic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Polycystic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Polycystic Kidney Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Polycystic Kidney Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Polycystic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 32
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 35
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kadmon Corporation, LLC, 2015* 37
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 38
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 39
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Diablo Clinical Research, Inc., 2015* 40
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 41
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Pharmaceuticals, Inc., 2015* 42
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2015* 43
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2015* 44
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mario Negri Institute for Pharmacological Research, 2015* 45
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 46
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2015* 47
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 48
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Toranomon Hospital, 2015* 49
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Addenbrooke's Hospital, 2015* 50
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 51
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Ospedale Policlinico Consorziale, 2015* 52

List of Figures
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Polycystic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Polycystic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Polycystic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Polycystic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Polycystic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Polycystic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.